bioRxivPathology
Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic Neuropathy
A. M. Warwick, H. M. Bomze, L. Wang, M. Klingeborn, Y. Hao, S. Stinnett, S. Gospe
Abstract
PurposeTo test whether continuous hypoxia is neuroprotective to retinal ganglion cells (RGCs) in a mouse model of mitochondrial optic neuropathy. MethodsRGC degeneration was assessed in genetically modified mice in which the floxed gene for the complex I subunit NDUFS4 is deleted from RGCs using Vlgut2-driven Cre recombinase. Beginning at postnatal day 25 (P25), Vglut2-Cre;ndufs4loxP/loxP mice and control littermates were housed under hypoxia (11% oxygen) or were kept under normoxia (21% oxygen). Survival of RGC somas and axons was assessed at P60 and P90 via histological analysis of retinal flat mounts and optic nerve cross sections, respectively. Retinal tissue was also assessed for neuroinflammation using Western blot and confocal microscopy. ResultsConsistent with our previous characterization of this model, at least one-third of RGCs had degenerated by P60 in Vglut2-Cre;ndufs4loxP/loxP mice remaining under normoxia. However, continuous hypoxia resulted in complete rescue of RGC somas and axons at this time point, with normal axonal myelination observed on electron microscopy. Though only partial, hypoxia-mediated rescue of complex I-deficient RGC somas and axons remained significant at P90. Hypoxia prevented reactive gliosis at P60, while the retinal accumulation of Iba1-positive mononuclear inflammatory cells was not substantially reduced. ConclusionsContinuous hypoxia achieved dramatic rescue of early RGC degeneration in mice with severe mitochondrial dysfunction. Although complete rescue was not durable to P90, our observations suggest that investigating the mechanisms underlying hypoxia-mediated neuroprotection of RGCs may identify useful therapeutic strategies for optic neuropathies resulting from less profound mitochondrial impairment, such as Leber Hereditary Optic Neuropathy.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pharmacological Depletion of Retinal Mononuclear Phagocytes is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy
Avital Lily Okrent Smolar, Rahul Viswanath, … Sidney M. Gospe·Investigative Ophthalmology & Visual SciencePeer-reviewed·Feb 2, 2026
- Cell-Intrinsic Vulnerability and Immune Activation Cooperate to Drive Degeneration in a Mitochondrial Complex I Deficiency Model of Optic Neuropathy
Daniela Santamaría-Muñoz, Raenier V. Reyes, … Anna La Torre·Journal of NeuroinflammationPeer-reviewed·Feb 6, 2026
- A paradoxical relationship between mitochondrial calcium regulation and retinal ganglion cell degeneration after axon damage
Sean McCracken, Minglei Zhao, … Philip Raymond Williams·bioRxiv·May 15, 2026
- Genetic and pharmacological correction of impaired mitophagy in retinal ganglion cells rescues glaucomatous neurodegeneration
Prabhavathi Maddineni, Bindu Kodati, … Gulab S Zode·bioRxiv·Feb 13, 2025
- The Mitochondria-Targeted Peptide HDAP2 Reduces Mitochondrial Loss and Retinal Ganglion Cell Degeneration After Optic Nerve Injury
Margaret A. MacNeil, Sara Arain, … Alexander Victor Birk·NeurosciencePeer-reviewed·Feb 1, 2026
- Regulation of Diseases-Associated Microglia in the Optic Nerve by Lipoxin B4 and Ocular Hypertension
Shubham Maurya, Maggie Lin, … Karsten Gronert·Molecular NeurodegenerationPeer-reviewed·Nov 20, 2024